論文

査読有り 責任著者 国際誌
2019年12月6日

CRISPR-Cas3 induces broad and unidirectional genome editing in human cells.

Nature communications
  • Hiroyuki Morisaka
  • Kazuto Yoshimi
  • Yuya Okuzaki
  • Peter Gee
  • Yayoi Kunihiro
  • Ekasit Sonpho
  • Huaigeng Xu
  • Noriko Sasakawa
  • Yuki Naito
  • Shinichiro Nakada
  • Takashi Yamamoto
  • Shigetoshi Sano
  • Akitsu Hotta
  • Junji Takeda
  • Tomoji Mashimo
  • 全て表示

10
1
開始ページ
5302
終了ページ
5302
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1038/s41467-019-13226-x

Although single-component Class 2 CRISPR systems, such as type II Cas9 or type V Cas12a (Cpf1), are widely used for genome editing in eukaryotic cells, the application of multi-component Class 1 CRISPR has been less developed. Here we demonstrate that type I-E CRISPR mediates distinct DNA cleavage activity in human cells. Notably, Cas3, which possesses helicase and nuclease activity, predominantly triggered several thousand base pair deletions upstream of the 5'-ARG protospacer adjacent motif (PAM), without prominent off-target activity. This Cas3-mediated directional and broad DNA degradation can be used to introduce functional gene knockouts and knock-ins. As an example of potential therapeutic applications, we show Cas3-mediated exon-skipping of the Duchenne muscular dystrophy (DMD) gene in patient-induced pluripotent stem cells (iPSCs). These findings broaden our understanding of the Class 1 CRISPR system, which may serve as a unique genome editing tool in eukaryotic cells distinct from the Class 2 CRISPR system.

リンク情報
DOI
https://doi.org/10.1038/s41467-019-13226-x
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/31811138
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6897959
ID情報
  • DOI : 10.1038/s41467-019-13226-x
  • PubMed ID : 31811138
  • PubMed Central 記事ID : PMC6897959

エクスポート
BibTeX RIS